Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atosiban in threatened preterm birth
NCT03570294Completed
- Sponsor
- Instytut Centrum Zdrowia Matki Polki
- Start
- Feb 2014
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atosiban in preterm birth, sponsored by Instytut Centrum Zdrowia Matki Polki. Primary endpoint: Delay preterm delivery for 48 hours. Started Feb 2014; status: completed.
02
Drugs
atosiban
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT03570294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03570294.